Is Vaccine a Silver Lining for the COVID Pandemic?

Опубликовано: 11 Июнь 2026
на канале: One Health Bangladesh
50
1

One Health Bangladesh, a multidisciplinary platform dealing with health threats at the human-animal - environmental interface, has been organizing a series of webinars in response to the COVID-19 pandemic. The set of webinars is being organized in partnership with Global Health Development (GHD).

The COVID-19 pandemic is continuing to spread across the world and claim life. South Asian countries, including Bangladesh, are facing tremendous challenges to tackle health threats. In many ways, the COVID-19 pandemic has proven to be a moving target. One Health approach recognizes the interconnectedness of human-animal in a complex ecosystem. It promotes the multidisciplinary and multisectoral coordination at the local, national, regional, and global level to tackle future pandemic like COVID-19.

Join us on Friday the 17th of July at 5 pm Bangladesh time for the 11th weekly interactive webinar on “Is Vaccine a Silver Lining for the COVID Pandemic?". The webinar will focus on the recent development and challenges of getting vaccines of COVID-19. The webinar will also focus on the One Health aspect of vaccine development for other zoonotic diseases.


Introducing Key Speakers
Dr. Firdausi Qadri, Emeritus Scientist, Infectious Diseases Division, icddrb has been working in Bangladesh in collaboration with international and national organizations on research related to infectious diseases and vaccine development over the last three decades. Trained as a biochemist with specialization in immunology and infectious disease research her key scientific achievements lie in enteric and diarrheal infections and vaccines including Vibrio cholerae Details here

Dr. Michael James Francis, Managing Director, BioVacc Consulting Ltd. Michael Francis has over 40 years of experience in vaccine research and development and has published more than 125 scientific papers. He obtained his Ph.D. in viral immunology from the University of Surrey, UK, and began his scientific career at the Wellcome Foundation Foot-and-Mouth Disease Vaccine Laboratories, where he studied the immune response to FMD vaccination. Details here

The webinar will be moderated by Prof Nitish Debnath, National Coordinator, One Health Bangladesh.